These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27306699)

  • 41. Montreal Cognitive Assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis.
    Paraizo Mde A; Almeida AL; Pires LA; Abrita RS; Crivellari MH; Pereira Bdos S; Fernandes NM; Bastos MG
    J Bras Nefrol; 2016 Mar; 38(1):31-41. PubMed ID: 27049362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The predictive value of serum p-CREB level on secondary cognitive impairment in patients with mild-to-moderate craniocerebral trauma.
    Han C; Yang Y; Ruan S; Guo L; Zhang X; Guan Q
    Neurosurg Rev; 2019 Sep; 42(3):715-720. PubMed ID: 30607616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Olfactory dysfunction is a risk factor for the comorbidity of mild cognitive impairment and Type 2 diabetes mellitus.
    Gong L; Xie J; Liu J; Tang G; Lin W; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):831-837. PubMed ID: 34565726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive function and insulin resistance in elderly patients with type 2 diabetes.
    Ma L; Li Y
    Neurol Res; 2017 Mar; 39(3):259-263. PubMed ID: 28107806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation between Exogenous Insulin and Cognitive Function in Type 2 Diabetes Mellitus.
    Šimonienė D; Veličkienė D
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577866
    [No Abstract]   [Full Text] [Related]  

  • 46. Modulation of insulin degrading enzyme activity and liver cell proliferation.
    Pivovarova O; von Loeffelholz C; Ilkavets I; Sticht C; Zhuk S; Murahovschi V; Lukowski S; Döcke S; Kriebel J; de las Heras Gala T; Malashicheva A; Kostareva A; Lock JF; Stockmann M; Grallert H; Gretz N; Dooley S; Pfeiffer AF; Rudovich N
    Cell Cycle; 2015; 14(14):2293-300. PubMed ID: 25945652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment.
    Gorska-Ciebiada M; Saryusz-Wolska M; Borkowska A; Ciebiada M; Loba J
    Metab Brain Dis; 2016 Apr; 31(2):257-66. PubMed ID: 26432692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction model for mild cognitive impairment in patients with type 2 diabetes using the autonomic function test.
    Kang H; Kim J; Kim M; Kim JH; Roh GS; Kim SK
    Neurol Sci; 2024 Aug; 45(8):3757-3766. PubMed ID: 38520638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased Serum Trimethylamine N-Oxide Level in Type 2 Diabetic Patients with Mild Cognitive Impairment.
    Xu N; Wan J; Wang C; Liu J; Qian C; Tan H
    Diabetes Metab Syndr Obes; 2022; 15():2197-2205. PubMed ID: 35923251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 51. Effectiveness of Montreal Cognitive Assessment for the diagnosis of mild cognitive impairment and mild Alzheimer's disease in Singapore.
    Ng A; Chew I; Narasimhalu K; Kandiah N
    Singapore Med J; 2013 Nov; 54(11):616-9. PubMed ID: 24276096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced Serum Levels of Klotho are Associated with Mild Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.
    Zhang H; Yu L; Yun G
    Diabetes Metab Syndr Obes; 2023; 16():129-137. PubMed ID: 36760583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mild cognitive impairment in psoriatic arthritis: Prevalence and associated factors.
    Di Carlo M; Becciolini A; Incorvaia A; Beci G; Smerilli G; Biggioggero M; Tardella M; De Angelis R; Salaffi F
    Medicine (Baltimore); 2021 Mar; 100(11):e24833. PubMed ID: 33725953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Plasma DPP4 Activity With Mild Cognitive Impairment in Elderly Patients With Type 2 Diabetes: Results From the GDMD Study in China.
    Zheng T; Qin L; Chen B; Hu X; Zhang X; Liu Y; Liu H; Qin S; Li G; Li Q
    Diabetes Care; 2016 Sep; 39(9):1594-601. PubMed ID: 27371673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physical and sociopsychological characteristics of older community residents with mild cognitive impairment as assessed by the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Kawai H; Hirano H; Yoshida H; Kojima M; Ihara K; Obuchi S
    J Geriatr Psychiatry Neurol; 2013 Dec; 26(4):209-20. PubMed ID: 23920040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum concentration of dihomo-γ-linolenic acid is associated with cognitive function and mild cognitive impairment in coronary artery disease patients.
    Ishihara K; Izawa KP; Kitamura M; Shimogai T; Kanejima Y; Morisawa T; Shimizu I
    Prostaglandins Leukot Essent Fatty Acids; 2020 Jul; 158():102038. PubMed ID: 31767440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance.
    Abdul-Hay SO; Kang D; McBride M; Li L; Zhao J; Leissring MA
    PLoS One; 2011; 6(6):e20818. PubMed ID: 21695259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In Addition to Poor Glycemic Control, a High Level of Irisin in the Plasma Portends Early Cognitive Deficits Clinically in Chinese Patients With Type 2 Diabetes Mellitus.
    Lin H; Yuan Y; Tian S; Han J; Huang R; Guo D; Wang J; An K; Wang S
    Front Endocrinol (Lausanne); 2019; 10():634. PubMed ID: 31572306
    [No Abstract]   [Full Text] [Related]  

  • 60. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels.
    Gu HF; Efendic S; Nordman S; Ostenson CG; Brismar K; Brookes AJ; Prince JA
    Diabetes; 2004 Aug; 53(8):2137-42. PubMed ID: 15277398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.